Roberta Marinelli of Eli Lilly: Addressing Obesity as a Progressive Disease

Published:

Addressing the Global Obesity Crisis: A Call to Action

The Growing Challenge of Obesity

In today’s healthcare landscape, obesity has emerged as one of the most urgent public health issues. This condition is not merely a personal struggle; it is a complex disease that requires a comprehensive approach. The World Health Organization (WHO) has redefined obesity as a chronic, relapsing disease, emphasizing the need for management akin to other serious health conditions. This shift in perspective is crucial for fostering understanding and compassion rather than perpetuating social stigma.

Global Leaders Unite for Change

On September 25, world leaders will gather at the Fourth High-Level Meeting of the United Nations General Assembly to address pressing noncommunicable diseases (NCDs) and mental health challenges. Key topics will include cardiovascular diseases, cancers, diabetes, and chronic respiratory illnesses, all of which are significantly influenced by obesity. As a primary risk factor for these conditions, obesity demands urgent attention and action.

Pioneering Initiatives in Abu Dhabi

The Department of Health in Abu Dhabi is leading the charge in transforming obesity management. On June 12, the UAE capital became one of the first regions globally to implement a reimbursement policy for non-surgical obesity treatments. This initiative represents a significant shift in healthcare policy, prioritizing scientific evidence and patient-centered care.

Despite this progressive step, many countries still fail to recognize obesity as a disease, leaving patients without access to necessary treatments. Abu Dhabi’s approach serves as a model, combining scientific acknowledgment of obesity with practical solutions, such as public coverage for innovative treatments like GLP-1 receptor agonists. This comprehensive strategy aims to integrate prevention, early intervention, and equitable access to care.

The Stigma Surrounding Obesity

Despite advancements in understanding obesity, many individuals still face social stigma and blame. It is essential to recognize that obesity is not a choice; it is influenced by a myriad of genetic, biological, environmental, and socioeconomic factors. Just as individuals do not choose to develop conditions like asthma or cancer, they do not choose obesity.

Currently, one in eight people globally lives with obesity, a figure projected to double by 2030. The health implications are severe, with obesity significantly increasing the risk of type 2 diabetes, cardiovascular disease, hypertension, and various cancers.

The Economic Impact of Obesity

The economic ramifications of obesity are equally concerning. If left unaddressed, the global cost associated with overweight and obesity could surpass $3 trillion annually by 2030. This figure encompasses lost productivity, premature deaths, and escalating healthcare costs. Even a modest reduction in obesity rates could yield substantial economic benefits; for instance, a 5% decrease could save the global economy $430 billion each year.

Addressing obesity is not just about reducing costs; it also enhances overall health and productivity, ultimately contributing to economic growth.

The Need for Swift Action

The urgency of addressing obesity cannot be overstated. Government policies must be implemented quickly to ensure that patients have timely access to care. Delays in access can hinder the positive outcomes these policies aim to achieve. By improving health outcomes and reducing long-term costs, Abu Dhabi exemplifies how public health investments can translate into national benefits.

A Global Template for Action

Abu Dhabi’s approach serves as a wake-up call for countries worldwide. By integrating clinical science with inclusive access, it sets a precedent for how to treat obesity as a serious disease. This model demonstrates that with effective government policy, scientific integrity, and coordinated efforts, we can make significant strides in combating obesity.

The Role of Innovation and Collaboration

At the forefront of this movement, organizations like Lilly are committed to advancing scientific innovations in obesity care. Developing effective therapies that address the root causes of obesity is essential, but it requires a collective effort. Governments, policymakers, healthcare providers, and communities must work together to create a coordinated response.

The time for action is now. By embracing a comprehensive approach to obesity, we can foster a healthier future for individuals and societies alike.

Share post:

Subscribe

Popular

More like this
Related

UAE space sector spending projected to reach AED 5.52 billion by 2025

The UAE's space sector is projected to reach AED 5.52 billion by 2025, marking a significant 27.1% increase from previous estimates, according to the 2025 Space Economic Survey presented by Engineer Salem Butti Al Qubaisi, Director General of the UAE…

German police arrest Russian man linked to cyber attack on London hospitals

German police have arrested a 28-year-old Russian man, identified as Vladimir K., in connection with a cyber attack that disrupted services at London hospitals and is linked to a patient's death. The incident, which involved the hacking of blood testing…

UAE leads AI investment surge with $678 million raised in H1 2026

The UAE has emerged as a leader in artificial intelligence investment, raising $678 million in the first half of 2026, marking an 81% increase year-on-year. This surge was highlighted at the Sharjah Investment Forum (SIF 2026), where industry leaders emphasized…

UAE enterprises prioritize AI readiness and cybersecurity amid economic pressures, says Dell study

A recent study by Dell Technologies highlights a significant shift in priorities among UAE enterprises, emphasizing the need for AI readiness and enhanced cybersecurity amid ongoing economic pressures. Conducted by Vanson Bourne, the Modern Enterprise Readiness Study 2026 surveyed 1,500…